Within a current study, we noted the identification plus the characterization of a fresh atypical opioid receptor with exceptional adverse regulatory Qualities toward opioid peptides.1 Our success confirmed that ACKR3/CXCR7, hitherto called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can also be a wide-spectrum scavenger for op